Severe Asthma in Children: Lessons Learned and Future Directions

Area of Science:

• Pediatric Pulmonology
• Allergy and Immunology
• Clinical Research

Background:

• Severe asthma in children is a complex, heterogeneous condition posing significant treatment challenges.
• A subset of children with severe asthma requires high-dose inhaled corticosteroids (ICS) and systemic steroids for symptom control.
• These children face increased risks of adverse effects and severe exacerbations, impacting quality of life.

Purpose of the Study:

• To review findings on severe asthma in school-aged children (6-17 years) from the National Heart, Lung, and Blood Institute's Severe Asthma Research Program (SARP).
• To summarize advancements in understanding the clinical, biological, and molecular characteristics of severe pediatric asthma over a decade (2001-2011).

Main Methods:

• Review of data from the Severe Asthma Research Program (SARP) spanning 10 years (2001-2011).
• Analysis of clinical, biological, and molecular attributes of severe asthma in school-aged children.

Main Results:

• The SARP initiative has enhanced understanding of severe pediatric asthma's unique features.
• Despite progress, significant knowledge gaps persist regarding the management and underlying mechanisms of severe asthma in children.

Conclusions:

• Severe asthma in children is a distinct phenotype requiring further investigation.
• Continued research is essential to address remaining gaps and improve treatment strategies for severe pediatric asthma.